Papers
1
Total Citations
5
H-Index
1
About
Manav Gideon is a rising surgical researcher whose work centers on optimizing outcomes in urologic oncology, with a particular focus on renal cell carcinoma (RCC) and partial nephrectomy (PN). His key contribution lies in rigorously comparing surgical modalities—open, laparoscopic, and robotic—to determine which approach yields the best functional and oncologic results for patients with localized kidney tumors. His highly cited 2024 study on Trifecta and Pentafecta outcomes provides a critical framework for surgeons, offering a standardized way to evaluate success beyond simple survival metrics. By analyzing complication rates, warm ischemia times, and renal function preservation, Gideon’s work directly informs clinical decision-making, helping to balance the complexity of tumor resection with the imperative of sparing healthy kidney tissue. With 5 citations already for this recent work, his findings are shaping best practices in a field where RCC accounts for 90% of kidney malignancies. Gideon’s research is particularly valuable for trainees and practicing urologists seeking evidence-based guidance on adopting robotic techniques, positioning him as an emerging authority in the evolution of nephron-sparing surgery.
Research Focus
Key Achievements
Top Papers
- 1